Did Elsevier break its own rules?

A science publisher that holds copyright supreme has a double standard, a science blogger is arguing. This week, science blogger Mike Dunford of linkurl:The Questionable Authority;http://scienceblogs.com/authority/ posted a linkurl:blog;http://scienceblogs.com/authority/2008/08/reed_elsevier_caught_copying_m.php saying that Reed Elsevier had copied some of the content from his blog without permission. While checking out links to his blog, Dunford came across a page run by LexisNexis (a Reed El

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
A science publisher that holds copyright supreme has a double standard, a science blogger is arguing. This week, science blogger Mike Dunford of linkurl:The Questionable Authority;http://scienceblogs.com/authority/ posted a linkurl:blog;http://scienceblogs.com/authority/2008/08/reed_elsevier_caught_copying_m.php saying that Reed Elsevier had copied some of the content from his blog without permission. While checking out links to his blog, Dunford came across a page run by LexisNexis (a Reed Elsevier company), which contained excerpts from one of Dunford's posts on open access from a few weeks ago, which mentioned Elsevier's profits from 2007. Dunford's name didn't appear anywhere on the LexisNexis page, although there was a link back to the original blog post. Reed Elsevier has some open access content but primarily operates under the traditional publishing model. They have been vocal in their linkurl:opposition;http://www.the-scientist.com/blog/display/54442/ to open access. In his post this week, Dunford said: "I was not asked for, and did not give, permission for my work to appear on that page, much less in that format. Needless to say, I felt a little slighted." In a statement from LexisNexis sent to the The Scientist, the company said that the page is part of an internal database set up for Elsevier to keep track of what's being said about them in the media. So what's Dunford's beef? "I guess on a scale of one to 10 this does not even register too highly when talking about things like copyright," he told The Scientist. But the frustration, he added, is that "Elsevier expects people to properly attribute their products." Just this June, Elsevier, the publishing arm of the company, filed a copyright infringement suit against Encyclopedia Britannica over medical illustrations appearing in the encyclopedia. "If they want standards with how to treat intellectual property," Dunford added, "that type of thing begins at home." In the statement, LexisNexis agreed that proper attribution was not given on the page. "Whenever Web content generated by third parties is used in this way, it is the practice of LexisNexis to use only a small amount of that content, and to provide attribution to the content's author, along with a link to the relevant blog or Web site," the statement noted. "Our investigation concluded that, in this particular instance, these procedures were not adhered to fully." LexisNexis added that it will apologize to Dunford, remove the content in question, and implement refresher training for their employees to make sure content is attributed properly. "LexisNexis is committed to respecting the rights of copyright holders and content owners," the statement concluded.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Andrea Gawrylewski

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide